摘要：在医学的浩瀚宇宙中，晚期癌症的治疗一直是医学界面临的重大挑战之一。面对这一顽疾，传统疗法往往陷入“非黑即白”的困境：或是采取激进的手术切除（白治），或是依赖强烈的化疗与放疗（黑治）。然而，在这两极之间，仝小林院士以其深邃的医学洞察力和人文关怀，提出了一种全新的
在医学的浩瀚宇宙中，晚期癌症的治疗一直是医学界面临的重大挑战之一。面对这一顽疾，传统疗法往往陷入“非黑即白”的困境：或是采取激进的手术切除（白治），或是依赖强烈的化疗与放疗（黑治）。然而，在这两极之间，仝小林院士以其深邃的医学洞察力和人文关怀，提出了一种全新的治疗策略——“灰治”，为晚期癌症患者开辟了一条新的生存之道。
“灰治”，顾名思义，是一种中庸之道，它摒弃了“一刀切”的极端思维，倡导在黑白之间寻找平衡，为患者提供更为温和、全面的治疗方案。仝小林院士认为，对于那些肿瘤已转移或患者年龄较大、体质较弱的情况，手术和放化疗的激进手段可能并不适宜，反而可能加速患者身体的衰败。此时，“灰治”以其独特的优势，成为了更为合理的选择。
“灰治”的核心在于中医保守治疗。它不仅仅关注肿瘤本身，更重视患者整体机能的调理与恢复。中医理论认为，人体是一个复杂而精密的系统，疾病的发生与脏腑功能失调、气血失衡密切相关。因此，在治疗晚期癌症时，中医更注重调和阴阳、扶正祛邪，通过调整患者的内环境，提高机体的抗病能力，从而达到带瘤生存的目的。
梁世杰主任，在基层中医肿瘤治疗领域小有名气，他经常提及的带瘤生存的中医治疗方式，正是“灰治”理念的生动实践。他强调，保命疗法不是简单地追求肿瘤的消除，而是要在保证患者生活质量的前提下，实现肿瘤与机体的和谐共存。这种治疗方式，既避免了激进疗法带来的身体损伤，又为患者提供了延长生命、提高生存质量的可能。
举一个具体的例子，张先生是一位晚期肺癌患者，当西医告诉他手术和放化疗都已无能为力时，他转而寻求中医治疗。梁世杰主任根据他的病情，采用了中药内服，旨在调和气血、增强体质。经过几个月的治疗，张先生的身体状况明显好转，虽然肿瘤依然存在，但他的生活质量得到了显著提升，精神状态良好，甚至能够进行一些轻度的家务劳动。这正是“灰治”理念下带瘤生存治疗方式的成功实践。
“灰治”不仅体现了医学的人文关怀，更是对传统治疗模式的一次深刻反思与革新。它告诉我们，在面对晚期癌症这一复杂而棘手的问题时，我们需要跳出固有的思维框架，以更加开放、包容的心态去探索新的治疗路径。在这个过程中，中医以其独特的理论体系和治疗手段，为我们提供了宝贵的思路和启示。
总之，“灰治”作为晚期癌症治疗的一种智慧之选，不仅为患者提供了新的生存希望，也推动了医学界对于疾病治疗模式的深刻思考。在未来，我们有理由相信，随着中西医结合的深入发展，“灰治”理念将在更多领域得到应用和推广，为人类的健康事业贡献更多的智慧和力量。
作者简介：梁世杰 中医高年资主治医师，从事中医临床工作24年，积累了较丰富的临床经验。师从首都医科大学附属北京中医院肝病科主任医师、著名老中医陈勇，侍诊多载，深得器重，尽得真传！擅用“商汤经方分类疗法”、专病专方结合“焦树德学术思想”“关幼波十纲辨证”学术思想治疗疑难杂症为特色。现任北京厚德为怀医生集团渐冻症研究中心主任，北京树德堂中医研究院研究员，北京中医药薪火传承新3+3工程—焦树德门人（陈勇）传承工作站研究员，国际易联易学与养生专委会常务理事，中国中医药研究促进会焦树德学术传承专业委员会委员，中国药文化研究会中医药慢病防治分会首批癌症领域入库专家。荣获2020年中国中医药研究促进会仲景医学分会举办的第八届医圣仲景南阳论坛“经方名医”荣誉称号。2023年首届京津冀“扁鹊杯”燕赵医学研究主题征文优秀奖获得者。
Grey's Cure: Wisdom for Advanced cancer Treatment - Exploring Traditional Chinese Medicine for Cancer Survival
In the vast universe of medicine, the treatment of advanced cancer has always been one of the major challenges facing the medical profession. In the face of this persistent disease, traditional treatments often find themselves in a "black or white" dichotomy: either with aggressive surgical removal (white treatment) or relying on intense chemotherapy and radiation (black treatment). Between these two poles, however, academician Tong Xiaoping, with his deep medical insight and human concern, has proposed a new treatment strategy - "gray cure," which has opened up a new way of survival for patients with advanced cancer.
Grey therapy, as its name suggests, is a moderate approach that rejects extreme "one size fits all" thinking and advocates finding a balance between black and white to offer patients a more gentle, comprehensive treatment. Professor Tong believes that for those cases where the tumor has metastasized or where the patient is older and weaker, aggressive means of surgery and chemotherapy may not be appropriate, but may accelerate the decay of the patient's body. At this time, Grey's became a more reasonable choice with its unique advantages.
The core of "gray cure" lies in traditional Chinese medicine for conservative treatment. It focuses not only on the tumor itself, but also on the overall functioning and recovery of the patient. TCM theory believes that the human body is a complex and sophisticated system, and the occurrence of diseases is closely related to dysfunction of the meridians and imbalance of the qi and blood. Therefore, when treating advanced cancer, traditional Chinese medicine pays more attention to reconciling yin and yang, supporting right and healing evil, and improving the body's disease resistance by adjusting the patient's internal environment, thereby achieving tumor-carrying survival.
Director Liang Shijie is little known in the field of primary-level traditional Chinese medicine oncology treatment. The traditional Chinese treatment for tumor survival he often mentions is a vivid practice of the concept of "gray cure." He emphasized that life-saving therapy is not simply to pursue the elimination of the tumor, but to achieve the harmonious coexistence of the tumor and the body on the premise of ensuring the quality of life of the patient. This type of treatment avoids the physical damage caused by radical therapy, but also provides patients with the possibility of prolonging their lives and improving their quality of life.
To give a specific example, Mr. Zhang, a patient with advanced lung cancer, turned to traditional Chinese medicine when Western medicine told him there was nothing he could do about surgery and chemotherapy. Director Liang Shijie took traditional Chinese medicine for oral administration according to his condition, aiming at harmonizing qi and blood and strengthening constitution. After several months of treatment, Mr. Zhang's physical condition has improved significantly. Although the tumor is still present, his quality of life has improved dramatically, his mental state is good, and he is even able to perform some mild domestic tasks. This is the successful practice of tumor survival treatment under the philosophy of "grey treatment."
"Grey treatment" not only reflects the humane concern of medicine, but also represents a profound rethinking and innovation of the traditional treatment model. It shows us that in the face of the complex and intractable problem of late-stage cancer, we need to think outside the box and explore new treatment pathways with a more open and inclusive mindset. In this process, traditional Chinese medicine has provided us with valuable ideas and inspiration with its unique theoretical system and treatment methods.
In short, "grey treatment" as a wise choice for advanced cancer treatment not only provides patients with new hope for survival, but also promotes the medical community's profound thinking about the disease treatment model. In the future, we have reason to believe that with the deep development of combination of Chinese and Western medicine, the concept of "grey cure" will be applied and promoted in more fields, contributing more wisdom and strength to the cause of human health.
Author Bio: Liang Shijie is a senior medical practitioner in traditional Chinese medicine. He has been engaged in traditional medicine clinical work for 24 years and has accumulated a wealth of clinical experience. Following Chen Yong, chief physician of liver disease at Beijing Traditional Medicine Hospital, affiliated with Capital Medical University, and renowned old Chinese medicine, he has been treated for many years and received great attention. He specializes in the treatment of difficult diseases using "conversational traditional therapy" and special treatments combined with the academic ideas of Jiao Shude and Guan Yubo's ten-level diagnosis.He is currently the director of the Center for Diffusion Research of Dr. Houde Wei Group in Beijing, a researcher at the Shude Tang Institute of Chinese Medicine, and a fellow at the new 3 + 3 project of traditional Chinese medicine flame inheritance in Beijing - a scholar at the inheritance work station of Jiao Shude's protégés (Chen Yong),He is a standing committee member of the International Expert Committee on E-learning and Health Care, a member of the Jiao Shude Academic Heritage Special Committee of the Chinese Association for the Advancement of Chinese Medicine Research, and the first cancer specialist to be included in the chapter of the Chinese Pharmaceutical Culture Research Association. Won the 2020 China Association for the Promotion of Traditional Chinese Medicine Zhongjing Medical Branch held the eighth session of the Medical Saint Zhongjing Nanyang Forum "Classic Prescription Famous Doctor" honorary title. The winner of the first Beijing-Tianjin-Hebei "Pingui Cup" Yanzhao Medical Research Essay Award in 2023.
来源：首都专家梁世杰